06/17/2026
Why does the FTC's insulin case matter?
Because it highlights a question millions of Americans are asking:
Why are prescription drugs so expensive, and who decides what we pay?
The FTC alleged that the nation's largest PBMs, Caremark, Express Scripts, and Optum Rx, used practices that may have contributed to higher insulin costs.
These companies play a major role in managing prescription drug benefits for millions of patients, making their decisions an important part of the healthcare conversation.
The case has sparked growing discussions around:
✔ Transparency in drug pricing
✔ Accountability across the healthcare system
✔ How prescription benefits are managed
✔ What patients should know about medication costs
Recent reforms are already pushing for greater oversight and clearer reporting requirements.
Because patients deserve more than a price at the pharmacy counter.
They deserve to understand how that price was determined.
We want to hear from you 👇
Do you think prescription drug pricing is transparent enough today?
Should patients have more visibility into how medication costs are determined?
Senator Katie Boyd Britt Senator Tommy Tuberville Rep. Terri Sewell Congressman Gary Palmer U.S. Representative Barry Moore Rep. Shomari Figures Congressman Mike D. Rogers Robert Aderholt Representative Dale Strong National Community Pharmacists Association American Pharmacists Association
